1) Fenofibric acid
非诺贝酸
1.
A HPLC method for determination of fenofibric acid in human plasma was established.
建立了HPLC法测定人血浆中非诺贝酸。
2) Fenofibric acid
非诺贝特酸
1.
Determination of fenofibric acid in rabbits plasma by HPLC;
反相高效液相色谱法测定家兔非诺贝特酸的血药浓度
2.
OBJECTIVE To establish a simple extract method for the analysis and quantitative determination of fenofibric acid in plasma,and compare relative bioavailability of fenofibrate test preparations with reference preparations in healthy volunteers.
目的建立非诺贝特酸简单快速的血浆样品提取方法,比较研究2种进口非诺贝特的人体相对生物利用度。
3) fenofibrate
非诺贝特
1.
Study on combined therapy with small-dose fluvastatin and fenofibrate in elderly patients with combined hyperlipidemia;
小剂量氟伐他汀联合非诺贝特治疗老年混合型高脂血症的临床研究
2.
Effects of fenofibrate on adiponectin and visfatin plasma concentrations in rats with lipid-induced insulin resistance;
非诺贝特对高脂饮食诱导胰岛素抵抗大鼠血浆脂联素和内脂素的影响
3.
Rhabdomyolysis resulting from fenofibrate;
非诺贝特引起横纹肌溶解症
4) Micronised fenofibrate
微粒化非诺贝特
1.
Effect of micronised fenofibrate on the treatment of diabetes mellitus dyslipidemia and on the C-reactive protein;
微粒化非诺贝特治疗糖尿病血脂异常及其对血清C-反应蛋白的影响
2.
Objective To investigate the effects of micronised fenofibrate treatment on carotid artery intima-media thickness (IMT) and cerebrovascular hemodynamics(CVA)in patients with essential hypertension.
目的 探讨微粒化非诺贝特对原发性高血压患者颈动脉内膜中层厚度 (IMT)与脑循环动力学 (CVA)的影响。
5) Lipantil capsule
非诺贝特胶囊
1.
OBJECTIVE: To study bioequiavailability of two preparations of Lipantil capsule micronized in human body.
目的评价非诺贝特胶囊(微粒化)2种制剂的生物等效性。
6) procetofen/PD
非诺贝特/药理学
补充资料：非诺贝酸
分子式：C17H15ClO4
分子量：318.76
CAS号：42017-89-0
性质：暂无
制备方法：暂无
用途：非诺贝特的中间体。
分子量：318.76
CAS号：42017-89-0
性质：暂无
制备方法：暂无
用途：非诺贝特的中间体。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条